kt 5823 has been researched along with Breast Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beyer, S; Jhiang, S; Lakshmanan, A; Liu, YY; Smolenski, A; Wapnir, I; Zhang, X | 1 |
1 other study(ies) available for kt 5823 and Breast Cancer
Article | Year |
---|---|
KT5823 differentially modulates sodium iodide symporter expression, activity, and glycosylation between thyroid and breast cancer cells.
Topics: Animals; Breast Neoplasms; Brefeldin A; Carbazoles; Cell Line; Female; Gene Expression Regulation, Neoplastic; Glycosylation; Humans; Hydrocortisone; Iodides; Protein Kinase Inhibitors; Protein Synthesis Inhibitors; Rats; Symporters; Thyroid Gland; Thyrotropin; Tretinoin | 2011 |